Cite
HARVARD Citation
Amoury, M. et al. (n.d.). A novel approach for targeted elimination of CSPG4‐positive triple‐negative breast cancer cells using a MAP tau‐based fusion protein. International journal of cancer. 139 (4), pp. 916-927. [Online].